In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
|Articles|November 24, 2014
GE Debuts PET/MR
Author(s)Diagnostic Imaging Staff
GE Healthcare will debut at RSNA 2014 their SIGNA PET/MR system.
Advertisement
GE Healthcare will showcase at RSNA 2014 the SIGNA PET/MR, which GE calls the world’s first time-of-flight capable, integrated, simultaneous PET/MR system.
The SIGNA PET/MR is powered by simultaneous image acquisition from GE’s latest 3.0 Tesla magnetic resonance (MR) technology, and innovative positron emission tomography (PET) technology and offers clinicians improved scan efficiency that may lead to more effective treatment paths, GE said.
The SIGNA PET/MR features GE’s MR-compatible silicon photomultiplier detector (SiPM) technology, which is categorized by its enhanced sensitivity, GE said. It also features fast coincidence timing resolution, enabling TOF reconstruction, GE said. TOF helps to improve PET image quality with the potential for higher structural detail and signal-to-noise ratio, GE said. The SIGNA PET/MR should be fully upgradable form a Discovery MR750w 3.0T.
The SIGNA PET/MR is 510(k) pending at the FDA.
Advertisement
Related to this article
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.
For patients with small cell lung cancer (SCLC), there was a 40 percent improvement in cognitive failure-free survival (CFFS) with brain MRI alone in comparison to the combination of brain MRI and prophylactic cranial irradiation (PCI), according to research presented at the ASTRO conference.
Catch up on the top radiology content of the past week.
In a recent interview, Shadpour Demehri, MD, discussed new research examining connections between deep learning assessment of bone mineral density on chest CT, brain MRI data and the potential for enhanced risk stratification in patients with diabetes.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Radiology and Building the Alzheimer’s Care Pathway of the Future
4
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
5